Share Issue, PDMR Dealings & Total Voting Rights

Strictly embargoed for: 07.00 a.m. on 8 December 2025

EMV Capital plc

(EMVC, Group or the Company)

Issue of Shares, Director/PDMR Dealings and Total Voting Rights

EMV Capital Plc (AIM: EMVC), the deep tech and life sciences VC investment group, announces the issue of 200,141 new ordinary shares of 5 pence each in the capital of the Company (Ordinary Shares) to certain of its directors and a PDMR in satisfaction of annual bonuses and fees (New Shares). The New Shares are being issued at a price of £0.55 per share. In addition, certain directors of the Company have purchased a total of 31,638 Ordinary Shares.

Issue of New Shares

Directors of the Company, Ilian Iliev, Ed Hooper, Jonathan Robinson and PDMR, Nick Salisbury, have agreed to receive New Shares (as detailed in the table below) in settlement of amounts owed to them by the Company rather than settlement in cash.

Such amounts owed are in the case of Ilian Iliev and Ed Hooper in respect of a proportion of the annual bonus awarded to them for the year ended 31 December 2024, in the case of Jonathan Robinson in respect of a proportion of outstanding fees and in the case of Nick Salisbury in respect of a proportion of a bonus payment for 2025. The New Shares are being issued at a price of £0.55 per share, being the average of the closing mid-market share price for the Ordinary Shares over the five dealing days prior to the date of this announcement.

Application will be made for the New Shares to be admitted to trading on AIM and it is expected that admission will take place on or around 12 December 2025 (Admission). The New Shares will rank pari passu in all respects with the Company's existing ordinary shares.

Purchase of Ordinary Shares

On 5 December 2025, the Company was notified that the following directors purchased Ordinary Shares through their Self Invested Personal Pensions, as detailed below (Director Dealings).

Directors Holdings

Following Admission and the Director Dealings, the Director's interests in the Ordinary Shares are as follows:

The information below, set out in accordance with the requirements of the UK Market Abuse Regulation, provides further detail on the issue of the Subscription Shares and the Director Dealings.

Total Voting Rights

Upon Admission, the issued share capital of the Company will consist of 27,967,532 Ordinary Shares (Enlarged Issued Share Capital). The Company does not hold any shares in treasury. Therefore, the total number of voting rights in the Company from Admission will be 27,967,532. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

The person responsible for arranging the release of this announcement on behalf of the Company is Ed Hooper, Executive Director and General Counsel of the Company.

-ends-

For more information, please contact:

About EMV Capital plc (EMVC)

EMV Capital plc is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies.

With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future; EMV Capital invests in, manages and strengthens early-stage IP-rich companies.

EMV Capital holds both direct equity stakes and carried interest in its portfolio companies, creating an evergreen structure that supports extensive growth and value creation. EMV Capital's investment thesis is realised through these capital sources:

·     capital-efficient investments through the Group balance sheet;

·     fund management of the Evergreen EIS and Martlet Capital Funds; and

·     syndicated investments leveraging its network of third-party investors.

EMV Capital's approach is characterised by its proactive management style, aiming to advance portfolio companies to critical value inflection points by actively engaging with them. Companies are supported through Board representation and the use of its Value Creation Services practice.

Headquartered in London, with a Cambridge presence and strong international links, EMV Capital is quoted on the AIM market of the London Stock Exchange.

www.emvcapital.com

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM